BDBM150971 US8981106, 161::USRE47267, Compound 161

SMILES OB(O)c1ccccc1CSc1ccc(cn1)C(=O)Nc1ccc(cc1)-c1nn[nH]n1

InChI Key InChIKey=BPNUTJCZHROWQH-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 150971   

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150971(US8981106, 161 | USRE47267, Compound 161)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2015
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150971(US8981106, 161 | USRE47267, Compound 161)
Affinity DataIC50: 1.00E+4nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150971(US8981106, 161 | USRE47267, Compound 161)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2016
Entry Details Article
PubMed